Implementation and challenges unique to teleretinal diabetic retinal screening (TDRS) in a private practice setting in the United States

Purpose: Adherence rates to published guidelines for diabetic retinopathy (DR) screening is between 35 and 60%. We evaluate a teleretinal DR screening (TDRS) program in a private practice vertically integrated system to increase compliance with retinal screening. Methods: A retrospective pre-post in...

Full description

Bibliographic Details
Main Authors: Chaitanya K. Mamillapalli, Jessi R. Prentice, Arvind K. Garg, Sunny L. Hampsey, Ramanath Bhandari
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Journal of Clinical & Translational Endocrinology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623719300213
Description
Summary:Purpose: Adherence rates to published guidelines for diabetic retinopathy (DR) screening is between 35 and 60%. We evaluate a teleretinal DR screening (TDRS) program in a private practice vertically integrated system to increase compliance with retinal screening. Methods: A retrospective pre-post intervention longitudinal study was conducted in a private endocrinology practice using TDRS as the primary intervention. Compliance rates for diabetic retinal screening were compared between December 31, 2016 and December 31, 2018. Results: A total population of 3479 patients were evaluated. Retinal screening compliance improved from 56.5% of patients (1964) pre-intervention to 59.3% of patients (2064) post intervention. The McNemar test was used for statistical analysis and found the change significant (p = 0.004). Conclusions: TDRS as an adjunct tool in a private practice endocrinology office significantly improved screening rates and can increase access to recommended diabetic eye care. However, the improvement in screening rates was smaller than other types of practice settings. We explore some of the unique challenges to implementation of TDRS in private practice settings. Keywords: Diabetes, Diabetic macular edema, Diabetic retinopathy, Diabetic screening, Telemedicine, Teleretinal
ISSN:2214-6237